AbbVie
ABBV
#26
Rank
NZ$595.18 B
Marketcap
$336.81
Share price
-0.24%
Change (1 day)
42.24%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: NZ$595.18 Billion

As of November 2024 AbbVie has a market cap of NZ$595.18 Billion. This makes AbbVie the world's 26th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AbbVie from 2012 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$595.18 B37.57%
2023NZ$432.64 B-3.89%
2022NZ$450.15 B28.45%
2021NZ$350.44 B33.67%
2020NZ$262.17 B34.84%
2019NZ$194.42 B-4.34%
2018NZ$203.24 B-6.51%
2017NZ$217.38 B47.97%
2016NZ$146.91 B5.43%
2015NZ$139.34 B4.84%
2014NZ$132.91 B30.29%
2013NZ$102.01 B55.48%
2012NZ$65.60 B

End of Day market cap according to different sources

On Nov 6th, 2024 the market cap of AbbVie was reported to be:

NZ$595.18 Billion
by Yahoo Finance info icon info icon
NZ$595.18 Billion
by CompaniesMarketCap info icon info icon
NZ$595.18 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$259.55 B-56.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$187.68 B-68.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.233 T 107.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$289.55 B-51.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$191.09 B-67.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$43.21 B-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$123.12 B-79.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$371.21 B-37.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$21.23 B-96.43%๐Ÿ‡บ๐Ÿ‡ธ USA